xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"
19. The name of the medicinal product.U.K.
20. The strength and pharmaceutical form of the product.U.K.
21. Where appropriate, whether the product is intended for babies, children or adults.U.K.
22. Where the product contains up to three active substances, the common name of each active substance.U.K.
23. The name of the holder of the [F1UK marketing authorisation, EU marketing authorisation], Article 126a authorisation or traditional herbal registration relating to the product.U.K.
Textual Amendments
F1Words in Sch. 24 para. 23 substituted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 201(3) (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 155(b)); 2020 c. 1, Sch. 5 para. 1(1)
24. The product's expiry date (month and year), in clear terms.U.K.
25. The manufacturer's batch number.U.K.